Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SALPHARM HOLDING ApS - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.0% 4.4% 5.0% 4.4% 1.9% 2.4% 4.9% 4.8%   Credit score (0-100)   51 47 42 47 69 64 44 45   Credit rating   BBB BBB BBB BBB A BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 28.0 1.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   33,244 45,690 55,250 54,455 55,408 71,154 0.0 0.0   EBITDA   18,702 33,000 40,113 39,182 37,950 49,582 0.0 0.0   EBIT   18,702 33,000 40,113 39,182 36,486 48,125 0.0 0.0   Pre-tax profit (PTP)   14,189.0 25,468.0 31,053.0 30,160.0 36,279.0 48,007.1 0.0 0.0   Net earnings   14,189.0 25,468.0 31,053.0 30,160.0 28,018.8 37,169.8 0.0 0.0   Pre-tax profit without non-rec. items   18,702 33,000 40,113 39,182 36,279 48,007 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 1,150 892 0.0 0.0   Shareholders equity total   23,386 48,969 45,027 43,723 51,786 60,723 11,130 11,130   Interest-bearing liabilities   0.0 0.0 0.0 0.0 97.8 181 0.0 0.0   Balance sheet total (assets)   47,441 59,387 62,100 65,279 79,698 92,220 11,130 11,130   Net Debt   0.0 0.0 0.0 0.0 -30,037 -28,415 -9,949 -9,949     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   33,244 45,690 55,250 54,455 55,408 71,154 0.0 0.0   Gross profit growth   0.0% 37.4% 20.9% -1.4% 1.8% 28.4% -100.0% 0.0%   Employees   6 16 18 20 25 29 0 0   Employee growth %   0.0% 166.7% 12.5% 11.1% 25.0% 16.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   47,441 59,387 62,100 65,279 79,698 92,220 11,130 11,130   Balance sheet change%   0.0% 25.2% 4.6% 5.1% 22.1% 15.7% -87.9% 0.0%   Added value   18,702.0 33,000.0 40,113.0 39,182.0 36,485.8 49,581.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 1,631 -449 -2,922 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   56.3% 72.2% 72.6% 72.0% 65.8% 67.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   39.4% 61.8% 66.0% 61.5% 50.9% 56.4% 0.0% 0.0%   ROI %   39.4% 61.8% 66.0% 61.5% 62.9% 85.5% 0.0% 0.0%   ROE %   60.7% 70.4% 66.1% 68.0% 58.7% 66.1% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   100.0% 100.0% 100.0% 100.0% 65.0% 65.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 0.0% -79.1% -57.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.2% 0.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 1,228.2% 352.6% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.0 0.0 0.0 1.7 1.5 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 2.8 2.8 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 30,134.9 28,596.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 0.0 0.0 48,752.1 56,993.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   3,117 2,063 2,229 1,959 1,459 1,710 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   3,117 2,063 2,229 1,959 1,518 1,710 0 0   EBIT / employee   3,117 2,063 2,229 1,959 1,459 1,659 0 0   Net earnings / employee   2,365 1,592 1,725 1,508 1,121 1,282 0 0